Genomic Biomarker Market 2025 to 2034
Genomic Biomarker Market 2025 to 2034
Genomic Biomarker Market (By Type: Predictive Biomarkers and Prognostic Biomarkers; By Disease Indication: Oncology, Cardiovascular Diseases, Neurological Diseases, Renal Disorders, and Others; By End-User: Hospitals, Diagnostic Centers, and Others; By Region: North America, Latin America, Europe, Asia-Pacific, and Middle East & Africa) Industry Size, Share, Growth, Trends, 2025–2034.
Customisation Request
Revenue, 2025
USD 6.04 Bn
Forecast Year, 2034
USD 10.98 Bn
CAGR, 2025 - 2034
6.83%
Report Coverage
Worldwide
Published By
Saurabh Bidwai
Reviewed By
Aditi Shivarkar
Reviewed By
Aman Singh
The genomic biomarker market is valued at USD 6.04 billion in 2025 and is projected to reach approximately USD 10.98 billion by 2034, expanding at a CAGR of 6.83%, driven by rising precision medicine adoption, advanced diagnostics, and growing oncology research investments.
Genomic Biomarker Market Size Analysis
Genomic Biomarker Market Size By_Type 2025 to 2034 (USD Billion)
| By_Type | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|
| Predictive Biomarkers | 3.50 | 3.75 | 4.02 | 4.31 | 4.63 | 4.96 | 5.32 | 5.70 | 6.11 | 6.55 |
| Prognostic Biomarkers | 2.54 | 2.70 | 2.87 | 3.05 | 3.24 | 3.44 | 3.66 | 3.89 | 4.14 | 4.40 |
Genomic Biomarker Market Size By_Disease_Indication 2025 to 2034 (USD Billion)
| By_Disease_Indication | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|
| Oncology | 2.78 | 2.99 | 3.21 | 3.46 | 3.71 | 3.99 | 4.30 | 4.61 | 4.96 | 5.33 |
| Cardiovascular Diseases | 1.09 | 1.15 | 1.23 | 1.30 | 1.39 | 1.47 | 1.56 | 1.66 | 1.76 | 1.87 |
| Neurological Diseases | 0.91 | 0.97 | 1.03 | 1.10 | 1.18 | 1.26 | 1.35 | 1.44 | 1.54 | 1.64 |
| Renal Disorders | 0.66 | 0.70 | 0.74 | 0.79 | 0.83 | 0.88 | 0.93 | 0.99 | 1.05 | 1.11 |
| Others | 0.60 | 0.64 | 0.68 | 0.71 | 0.76 | 0.80 | 0.84 | 0.89 | 0.94 | 1.00 |
Genomic Biomarker Market Size By_Region 2025 to 2034 (USD Billion)
| By_Region | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|
| North America | 2.30 | 2.43 | 2.59 | 2.74 | 2.93 | 3.11 | 3.30 | 3.51 | 3.73 | 3.96 |
| Europe | 1.63 | 1.74 | 1.85 | 1.97 | 2.09 | 2.23 | 2.37 | 2.52 | 2.69 | 2.86 |
| Asia Pacific | 1.33 | 1.44 | 1.56 | 1.69 | 1.83 | 1.97 | 2.14 | 2.31 | 2.50 | 2.70 |
| Latin America | 0.48 | 0.52 | 0.55 | 0.59 | 0.63 | 0.67 | 0.72 | 0.77 | 0.82 | 0.88 |
| Middle East and Africa | 0.30 | 0.32 | 0.34 | 0.37 | 0.39 | 0.42 | 0.45 | 0.48 | 0.51 | 0.55 |
Genomic Biomarker Market Size to Attain USD 10.98 Billion by 2034
The genomic biomarker market size was estimated at USD 6.04 bn in 2025 and is projected to be worth around USD 10.98 bn by 2034 a CAGR of 6.83%.
Proceed To Buy
Proceed To CheckoutMake Every Move Strategic. Get Insights, Fully Customized
- On-Demand Metrics & KPIs
- Industry-Specific Dashboards
- Quick Turnaround, No Compromises
Quick Contact
- NA : +1 804 441 9344
- APAC : +91 9356 9282 04
- EU : +44 7782 560 738
- sales@precedenceresearch.com
